|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
276:1665-1669
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural insights into the evolution of an antibody combining site.
|
|
G.J.Wedemayer,
P.A.Patten,
L.H.Wang,
P.G.Schultz,
R.C.Stevens.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structures of a germline antibody Fab fragment and its complex with
hapten have been solved at 2.1 A resolution. These structures are compared with
the corresponding crystal structures of the affinity-matured antibody, 48G7,
which has a 30,000 times higher affinity for hapten as a result of nine
replacement somatic mutations. Significant changes in the configuration of the
combining site occur upon binding of hapten to the germline antibody, whereas
hapten binds to the mature antibody by a lock-and-key fit mechanism. The
reorganization of the combining site that was nucleated by hapten binding is
further optimized by somatic mutations that occur up to 15 from bound hapten.
These results suggest that the binding potential of the primary antibody
repertoire may be significantly expanded by the ability of germline antibodies
to adopt more than one combining-site configuration, with both antigen binding
and somatic mutation stabilizing the configuration with optimal hapten
complementarity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Ribbon superpositions of the variable regions of the
germline Fab-hapten complex (light purple) and mature Fab-hapten
complex (dark red). The aliphatic linker used to conjugate the
hapten to the carrier protein can be seen extending toward the
top of^ the figure. The side chains of the somatic mutation
sites are^ indicated in light green (germ line) and dark green
(mature) (SerL30 Asn,
SerL34 Gly,
AspL55 His,
GluH42 Lys,
GlyH55 Val,
AsnH56 Asp,
GlyH65 Asp,
AsnH76 Lys,
Ala^H78 Thr).
|
 |
Figure 2.
Fig. 2. Superposition of the structures of the germline Fab
without hapten (light blue) and the germline Fab-hapten complex
(light purple), illustrating the structural changes that occur
on hapten binding to the germline Fab. In all figures, the
aliphatic linker of the hapten has been omitted for clarity.
Gray dotted lines denote hydrogen bonds in the structure of the
germline Fab without hapten, while black dotted lines denote
hydrogen bonds in the^ germline Fab-hapten complex. (A) CDR3 of
the heavy chain is reorganized on hapten binding. To make room
for the hapten, the side chain of TyrH99 moves 6 Å away
from the hapten. The side chain of TyrH98 moves 8.3 Å and
inserts between TyrH99 and TyrH33, and TyrH33 moves toward the
phosphonate group. These movements establish a -cation
interaction between the side chains of ArgL46 and TyrH99, a - interaction
between the aryl groups of TyrH99 and TyrH98, and a T-stack
interaction between the aryl rings of TyrH98 and TyrH33 (yellow
dotted lines). In addition, the ArgL46 side chain is stabilized
by salt bridges to the AspL55 carboxylate group and to the
TyrH99 main chain carbonyl group. (B) The interactions between
residues in CDR1, CDR2, and CDR3 of the heavy chain in the
germline^ Fab structures. The side chain of ArgH50 forms
hydrogen bonds to the hydroxyl groups of TyrH33 and TyrL94 upon
hapten binding. The guanidinium group of ArgH50 is positioned by
a hydrogen bond with AsnH56. Although TyrH33 forms one hydrogen
bond to ArgH50, it does not interact directly with either TyrL94
or the bound hapten, nor does LysH58 interact with residue H56
(cf. Fig. 3B). (C) Closeup of^ the combining site showing the
orientations of the residues directly involved in hapten binding
in the germline-hapten complex HisH35, TyrH33, and ArgL96. All
four hydrogen bonds are directed to the oxygens (red) of^ the
phosphonate group (phosphorus-yellow). TyrH33 moves 2.2 Å
toward the phosphonate group, which is a key binding determinant
in the hapten and is located in approximately the^ same position
in the combining sites of the germline and affinity-matured^
Fab-hapten complexes.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(1997,
276,
1665-1669)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.A.Weiser,
N.Wittenbrink,
L.Zhang,
A.I.Schmelzer,
A.Valai,
and
M.Or-Guil
(2011).
Affinity maturation of B cells involves not only a few but a whole spectrum of relevant mutations.
|
| |
Int Immunol,
23,
345-356.
|
 |
|
|
|
|
 |
S.E.Wong,
B.D.Sellers,
and
M.P.Jacobson
(2011).
Effects of somatic mutations on CDR loop flexibility during affinity maturation.
|
| |
Proteins,
79,
821-829.
|
 |
|
|
|
|
 |
C.L.Brooks,
A.Schietinger,
S.N.Borisova,
P.Kufer,
M.Okon,
T.Hirama,
C.R.Mackenzie,
L.X.Wang,
H.Schreiber,
and
S.V.Evans
(2010).
Antibody recognition of a unique tumor-specific glycopeptide antigen.
|
| |
Proc Natl Acad Sci U S A,
107,
10056-10061.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Zhang,
and
E.I.Shakhnovich
(2010).
Optimality of mutation and selection in germinal centers.
|
| |
PLoS Comput Biol,
6,
e1000800.
|
 |
|
|
|
|
 |
L.Zhao,
and
J.Li
(2010).
Mining for the antibody-antigen interacting associations that predict the B cell epitopes.
|
| |
BMC Struct Biol,
10,
S6.
|
 |
|
|
|
|
 |
C.E.Leysath,
A.F.Monzingo,
J.A.Maynard,
J.Barnett,
G.Georgiou,
B.L.Iverson,
and
J.D.Robertus
(2009).
Crystal structure of the engineered neutralizing antibody M18 complexed to domain 4 of the anthrax protective antigen.
|
| |
J Mol Biol,
387,
680-693.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.D.Boehr,
R.Nussinov,
and
P.E.Wright
(2009).
The role of dynamic conformational ensembles in biomolecular recognition.
|
| |
Nat Chem Biol,
5,
789-796.
|
 |
|
|
|
|
 |
N.Danilova,
and
C.T.Amemiya
(2009).
Going adaptive: the saga of antibodies.
|
| |
Ann N Y Acad Sci,
1168,
130-155.
|
 |
|
|
|
|
 |
R.Racine,
and
G.M.Winslow
(2009).
IgM in microbial infections: taken for granted?
|
| |
Immunol Lett,
125,
79-85.
|
 |
|
|
|
|
 |
V.Sharma,
W.Heriot,
K.Trisler,
and
V.Smider
(2009).
A human germ line antibody light chain with hydrolytic properties associated with multimerization status.
|
| |
J Biol Chem,
284,
33079-33087.
|
 |
|
|
|
|
 |
Y.Kim,
K.Kang,
I.Kim,
Y.J.Lee,
C.Oh,
J.Ryoo,
E.Jeong,
and
K.Ahn
(2009).
Molecular mechanisms of MHC class I-antigen processing: redox considerations.
|
| |
Antioxid Redox Signal,
11,
907-936.
|
 |
|
|
|
|
 |
C.A.Thomson,
S.Bryson,
G.R.McLean,
A.L.Creagh,
E.F.Pai,
and
J.W.Schrader
(2008).
Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.
|
| |
EMBO J,
27,
2592-2602.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.W.Debler,
R.Müller,
D.Hilvert,
and
I.A.Wilson
(2008).
Conformational isomerism can limit antibody catalysis.
|
| |
J Biol Chem,
283,
16554-16560.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Krishnan,
G.Sahni,
K.J.Kaur,
and
D.M.Salunke
(2008).
Role of antibody paratope conformational flexibility in the manifestation of molecular mimicry.
|
| |
Biophys J,
94,
1367-1376.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Singh,
and
J.M.Briggs
(2008).
Molecular dynamics simulations of Factor Xa: insight into conformational transition of its binding subsites.
|
| |
Biopolymers,
89,
1104-1113.
|
 |
|
|
|
|
 |
B.Moza,
A.K.Varma,
R.A.Buonpane,
P.Zhu,
C.A.Herfst,
M.J.Nicholson,
A.K.Wilbuer,
N.P.Seth,
K.W.Wucherpfennig,
J.K.McCormick,
D.M.Kranz,
and
E.J.Sundberg
(2007).
Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1.
|
| |
EMBO J,
26,
1187-1197.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.H.Holtzman,
K.Woronowicz,
D.Golemi-Kotra,
and
A.Schepartz
(2007).
Miniature protein ligands for EVH1 domains: interplay between affinity, specificity, and cell motility.
|
| |
Biochemistry,
46,
13541-13553.
|
 |
|
|
|
|
 |
J.Morfill,
K.Blank,
C.Zahnd,
B.Luginbühl,
F.Kühner,
K.E.Gottschalk,
A.Plückthun,
and
H.E.Gaub
(2007).
Affinity-matured recombinant antibody fragments analyzed by single-molecule force spectroscopy.
|
| |
Biophys J,
93,
3583-3590.
|
 |
|
|
|
|
 |
S.Minguet,
M.Swamy,
B.Alarcón,
I.F.Luescher,
and
W.W.Schamel
(2007).
Full activation of the T cell receptor requires both clustering and conformational changes at CD3.
|
| |
Immunity,
26,
43-54.
|
 |
|
|
|
|
 |
D.K.Sethi,
A.Agarwal,
V.Manivel,
K.V.Rao,
and
D.M.Salunke
(2006).
Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response.
|
| |
Immunity,
24,
429-438.
|
 |
|
|
|
|
 |
E.L.Roggen
(2006).
Recent developments with B-cell epitope identification for predictive studies.
|
| |
J Immunotoxicol,
3,
137-149.
|
 |
|
|
|
|
 |
H.Dooley,
R.L.Stanfield,
R.A.Brady,
and
M.F.Flajnik
(2006).
First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate.
|
| |
Proc Natl Acad Sci U S A,
103,
1846-1851.
|
 |
|
|
|
|
 |
J.M.Turner,
J.Graziano,
G.Spraggon,
and
P.G.Schultz
(2006).
Structural plasticity of an aminoacyl-tRNA synthetase active site.
|
| |
Proc Natl Acad Sci U S A,
103,
6483-6488.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Zimmermann,
E.L.Oakman,
I.F.Thorpe,
X.Shi,
P.Abbyad,
C.L.Brooks,
S.G.Boxer,
and
F.E.Romesberg
(2006).
Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.
|
| |
Proc Natl Acad Sci U S A,
103,
13722-13727.
|
 |
|
|
|
|
 |
K.S.Midelfort,
and
K.D.Wittrup
(2006).
Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment.
|
| |
Protein Sci,
15,
324-334.
|
 |
|
|
|
|
 |
M.M.Harmsen,
C.B.van Solt,
A.M.van Zijderveld-van Bemmel,
T.A.Niewold,
and
F.G.van Zijderveld
(2006).
Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy.
|
| |
Appl Microbiol Biotechnol,
72,
544-551.
|
 |
|
|
|
|
 |
N.S.Longo,
and
P.E.Lipsky
(2006).
Why do B cells mutate their immunoglobulin receptors?
|
| |
Trends Immunol,
27,
374-380.
|
 |
|
|
|
|
 |
B.Han,
P.Serra,
J.Yamanouchi,
A.Amrani,
J.F.Elliott,
P.Dickie,
T.P.Dilorenzo,
and
P.Santamaria
(2005).
Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
|
| |
J Clin Invest,
115,
1879-1887.
|
 |
|
|
|
|
 |
E.Vivier,
and
B.Malissen
(2005).
Innate and adaptive immunity: specificities and signaling hierarchies revisited.
|
| |
Nat Immunol,
6,
17-21.
|
 |
|
|
|
|
 |
J.C.Weill,
and
C.A.Reynaud
(2005).
Do developing B cells need antigen?
|
| |
J Exp Med,
201,
7-9.
|
 |
|
|
|
|
 |
K.Xie,
S.C.Song,
S.L.Spitalnik,
and
J.E.Wedekind
(2005).
Crystallographic analysis of the NNA7 Fab and proposal for the mode of human blood-group recognition.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
1386-1394.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Zheng,
R.Manetsch,
W.D.Woggon,
U.Baumann,
and
J.L.Reymond
(2005).
Mechanistic study of proton transfer and hysteresis in catalytic antibody 16E7 by site-directed mutagenesis and homology modeling.
|
| |
Bioorg Med Chem,
13,
1021-1029.
|
 |
|
|
|
|
 |
M.A.Lema,
and
J.Echave
(2005).
Assessing local structural perturbations in proteins.
|
| |
BMC Bioinformatics,
6,
226.
|
 |
|
|
|
|
 |
M.Krogsgaard,
and
M.M.Davis
(2005).
How T cells 'see' antigen.
|
| |
Nat Immunol,
6,
239-245.
|
 |
|
|
|
|
 |
M.T.Figge
(2005).
Stochastic discrete event simulation of germinal center reactions.
|
| |
Phys Rev E Stat Nonlin Soft Matter Phys,
71,
051907.
|
 |
|
|
|
|
 |
S.Cho,
C.P.Swaminathan,
J.Yang,
M.C.Kerzic,
R.Guan,
M.C.Kieke,
D.M.Kranz,
R.A.Mariuzza,
and
E.J.Sundberg
(2005).
Structural basis of affinity maturation and intramolecular cooperativity in a protein-protein interaction.
|
| |
Structure,
13,
1775-1787.
|
 |
|
|
|
|
 |
V.N.Uversky,
C.J.Oldfield,
and
A.K.Dunker
(2005).
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling.
|
| |
J Mol Recognit,
18,
343-384.
|
 |
|
|
|
|
 |
A.Cauerhff,
F.A.Goldbaum,
and
B.C.Braden
(2004).
Structural mechanism for affinity maturation of an anti-lysozyme antibody.
|
| |
Proc Natl Acad Sci U S A,
101,
3539-3544.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.L.Notkins
(2004).
Polyreactivity of antibody molecules.
|
| |
Trends Immunol,
25,
174-179.
|
 |
|
|
|
|
 |
A.Piatesi,
and
D.Hilvert
(2004).
Immunological optimization of a generic hydrophobic pocket for high affinity hapten binding and Diels-Alder activity.
|
| |
Chembiochem,
5,
460-466.
|
 |
|
|
|
|
 |
J.C.Weill,
S.Weller,
and
C.A.Reynaud
(2004).
A bird's eye view on human B cells.
|
| |
Semin Immunol,
16,
277-281.
|
 |
|
|
|
|
 |
J.Zhang,
A.M.Dean,
F.Brunet,
and
M.Long
(2004).
Evolving protein functional diversity in new genes of Drosophila.
|
| |
Proc Natl Acad Sci U S A,
101,
16246-16250.
|
 |
|
|
|
|
 |
M.B.Zwick,
H.K.Komori,
R.L.Stanfield,
S.Church,
M.Wang,
P.W.Parren,
R.Kunert,
H.Katinger,
I.A.Wilson,
and
D.R.Burton
(2004).
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
|
| |
J Virol,
78,
3155-3161.
|
 |
|
|
|
|
 |
M.Dono,
G.Cerruti,
and
S.Zupo
(2004).
The CD5+ B-cell.
|
| |
Int J Biochem Cell Biol,
36,
2105-2111.
|
 |
|
|
|
|
 |
R.Jimenez,
G.Salazar,
J.Yin,
T.Joo,
and
F.E.Romesberg
(2004).
Protein dynamics and the immunological evolution of molecular recognition.
|
| |
Proc Natl Acad Sci U S A,
101,
3803-3808.
|
 |
|
|
|
|
 |
S.C.Song,
K.Xie,
M.Czerwinski,
S.L.Spitalnik,
and
J.E.Wedekind
(2004).
Purification, crystallization and X-ray diffraction analysis of a recombinant Fab that recognizes a human blood-group antigen.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
788-791.
|
 |
|
|
|
|
 |
Z.H.Zhou,
and
A.L.Notkins
(2004).
Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.
|
| |
Clin Exp Immunol,
137,
88.
|
 |
|
|
|
|
 |
D.A.Kraut,
K.S.Carroll,
and
D.Herschlag
(2003).
Challenges in enzyme mechanism and energetics.
|
| |
Annu Rev Biochem,
72,
517-571.
|
 |
|
|
|
|
 |
E.Vargas-Madrazo,
and
E.Paz-García
(2003).
An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues.
|
| |
J Mol Recognit,
16,
113-120.
|
 |
|
|
|
|
 |
H.P.Nguyen,
N.O.Seto,
C.R.MacKenzie,
L.Brade,
P.Kosma,
H.Brade,
and
S.V.Evans
(2003).
Germline antibody recognition of distinct carbohydrate epitopes.
|
| |
Nat Struct Biol,
10,
1019-1025.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Yin,
S.E.Andryski,
A.E.Beuscher,
R.C.Stevens,
and
P.G.Schultz
(2003).
Structural evidence for substrate strain in antibody catalysis.
|
| |
Proc Natl Acad Sci U S A,
100,
856-861.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.C.James,
and
D.S.Tawfik
(2003).
Conformational diversity and protein evolution--a 60-year-old hypothesis revisited.
|
| |
Trends Biochem Sci,
28,
361-368.
|
 |
|
|
|
|
 |
M.Krogsgaard,
N.Prado,
E.J.Adams,
X.L.He,
D.C.Chow,
D.B.Wilson,
K.C.Garcia,
and
M.M.Davis
(2003).
Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation.
|
| |
Mol Cell,
12,
1367-1378.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Rodríguez,
L.Llanes,
A.Pérez,
R.Pérez,
and
A.M.Vázquez
(2003).
Generation and characterization of an anti-idiotype monoclonal antibody related to GM3(NeuGc) ganglioside.
|
| |
Hybrid Hybridomics,
22,
307-314.
|
 |
|
|
|
|
 |
P.Santamaria
(2003).
Kinetic evolution of a diabetogenic CD8+ T cell response.
|
| |
Ann N Y Acad Sci,
1005,
88-97.
|
 |
|
|
|
|
 |
R.Jimenez,
G.Salazar,
K.K.Baldridge,
and
F.E.Romesberg
(2003).
Flexibility and molecular recognition in the immune system.
|
| |
Proc Natl Acad Sci U S A,
100,
92-97.
|
 |
|
|
|
|
 |
S.Mohan,
N.Sinha,
and
S.J.Smith-Gill
(2003).
Modeling the binding sites of anti-hen egg white lysozyme antibodies HyHEL-8 and HyHEL-26: an insight into the molecular basis of antibody cross-reactivity and specificity.
|
| |
Biophys J,
85,
3221-3236.
|
 |
|
|
|
|
 |
Y.Li,
H.Li,
F.Yang,
S.J.Smith-Gill,
and
R.A.Mariuzza
(2003).
X-ray snapshots of the maturation of an antibody response to a protein antigen.
|
| |
Nat Struct Biol,
10,
482-488.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Ma,
M.Shatsky,
H.J.Wolfson,
and
R.Nussinov
(2002).
Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations.
|
| |
Protein Sci,
11,
184-197.
|
 |
|
|
|
|
 |
D.J.Tantillo,
and
K.N.Houk
(2002).
Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
|
| |
J Comput Chem,
23,
84-95.
|
 |
|
|
|
|
 |
E.J.Adams,
and
K.C.Garcia
(2002).
A T cell receptor goes public.
|
| |
Structure,
10,
1468-1469.
|
 |
|
|
|
|
 |
M.Meyer-Hermann
(2002).
Does recycling in germinal centres exist?
|
| |
Immunol Cell Biol,
80,
30-35.
|
 |
|
|
|
|
 |
N.Sinha,
S.Mohan,
C.A.Lipschultz,
and
S.J.Smith-Gill
(2002).
Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity.
|
| |
Biophys J,
83,
2946-2968.
|
 |
|
|
|
|
 |
B.Heymann,
and
H.Grubmüller
(2001).
Molecular dynamics force probe simulations of antibody/antigen unbinding: entropic control and nonadditivity of unbinding forces.
|
| |
Biophys J,
81,
1295-1313.
|
 |
|
|
|
|
 |
C.Rader
(2001).
Antibody libraries in drug and target discovery.
|
| |
Drug Discov Today,
6,
36-43.
|
 |
|
|
|
|
 |
D.J.Tantillo,
and
K.N.Houk
(2001).
Canonical binding arrays as molecular recognition elements in the immune system: tetrahedral anions and the ester hydrolysis transition state.
|
| |
Chem Biol,
8,
535-545.
|
 |
|
|
|
|
 |
E.Hendry,
G.Taylor,
F.Grennan-Jones,
A.Sullivan,
N.Liddy,
J.Godfrey,
N.Hayakawa,
M.Powell,
J.Sanders,
J.Furmaniak,
and
B.R.Smith
(2001).
X-ray crystal structure of a monoclonal antibody that binds to a major autoantigenic epitope on thyroid peroxidase.
|
| |
Thyroid,
11,
1091-1099.
|
 |
|
|
|
|
 |
K.Burgess,
I.Han,
A.Zhang,
W.H.Zheng,
K.Shanmugam,
M.S.Featherstone,
and
H.U.Saragovi
(2001).
DiSSiMiL: Diverse Small Size Mini-Libraries applied to simple and rapid epitope mapping of a monoclonal antibody.
|
| |
J Pept Res,
57,
68-76.
|
 |
|
|
|
|
 |
M.C.Ramirez-Benitez,
and
J.C.Almagro
(2001).
Analysis of antibodies of known structure suggests a lack of correspondence between the residues in contact with the antigen and those modified by somatic hypermutation.
|
| |
Proteins,
45,
199-206.
|
 |
|
|
|
|
 |
S.V.Taylor,
P.Kast,
and
D.Hilvert
(2001).
Investigating and Engineering Enzymes by Genetic Selection.
|
| |
Angew Chem Int Ed Engl,
40,
3310-3335.
|
 |
|
|
|
|
 |
T.Tsumuraya,
N.Takazawa,
A.Tsunakawa,
R.Fleck,
and
S.Masamune
(2001).
Catalytic antibodies induced by a zwitterionic hapten.
|
| |
Chemistry,
7,
3748-3755.
|
 |
|
|
|
|
 |
Y.Li,
C.A.Lipschultz,
S.Mohan,
and
S.J.Smith-Gill
(2001).
Mutations of an epitope hot-spot residue alter rate limiting steps of antigen-antibody protein-protein associations.
|
| |
Biochemistry,
40,
2011-2022.
|
 |
|
|
|
|
 |
A.Karlstrom,
G.Zhong,
C.Rader,
N.A.Larsen,
A.Heine,
R.Fuller,
B.List,
F.Tanaka,
I.A.Wilson,
C.F.Barbas,
and
R.A.Lerner
(2000).
Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task.
|
| |
Proc Natl Acad Sci U S A,
97,
3878-3883.
|
 |
|
|
|
|
 |
D.Hilvert
(2000).
Critical analysis of antibody catalysis.
|
| |
Annu Rev Biochem,
69,
751-793.
|
 |
|
|
|
|
 |
E.C.Mundorff,
M.A.Hanson,
A.Varvak,
H.Ulrich,
P.G.Schultz,
and
R.C.Stevens
(2000).
Conformational effects in biological catalysis: an antibody-catalyzed oxy-cope rearrangement.
|
| |
Biochemistry,
39,
627-632.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.J.Sundberg,
and
R.A.Mariuzza
(2000).
Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions.
|
| |
Structure,
8,
R137-R142.
|
 |
|
|
|
|
 |
E.T.Boder,
K.S.Midelfort,
and
K.D.Wittrup
(2000).
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity.
|
| |
Proc Natl Acad Sci U S A,
97,
10701-10705.
|
 |
|
|
|
|
 |
J.L.Xu,
and
M.M.Davis
(2000).
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.
|
| |
Immunity,
13,
37-45.
|
 |
|
|
|
|
 |
J.Maynard,
and
G.Georgiou
(2000).
Antibody engineering.
|
| |
Annu Rev Biomed Eng,
2,
339-376.
|
 |
|
|
|
|
 |
L.Choulier,
V.Lafont,
N.Hugo,
and
D.Altschuh
(2000).
Covariance analysis of protein families: the case of the variable domains of antibodies.
|
| |
Proteins,
41,
475-484.
|
 |
|
|
|
|
 |
M.Brown,
M.A.Schumacher,
G.D.Wiens,
R.G.Brennan,
and
M.B.Rittenberg
(2000).
The structural basis of repertoire shift in an immune response to phosphocholine.
|
| |
J Exp Med,
191,
2101-2112.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.M.Souto-Carneiro,
V.Krenn,
R.Hermann,
A.König,
and
H.K.Müller-Hermelink
(2000).
IgVH genes from different anatomical regions, with different histopathological patterns, of a rheumatoid arthritis patient suggest cyclic re-entry of mature synovial B-cells in the hypermutation process.
|
| |
Arthritis Res,
2,
303-314.
|
 |
|
|
|
|
 |
M.W.Cunningham
(2000).
Pathogenesis of group A streptococcal infections.
|
| |
Clin Microbiol Rev,
13,
470-511.
|
 |
|
|
|
|
 |
P.D.Holler,
P.O.Holman,
E.V.Shusta,
S.O'Herrin,
K.D.Wittrup,
and
D.M.Kranz
(2000).
In vitro evolution of a T cell receptor with high affinity for peptide/MHC.
|
| |
Proc Natl Acad Sci U S A,
97,
5387-5392.
|
 |
|
|
|
|
 |
P.U.Lee,
H.R.Churchill,
M.Daniels,
S.C.Jameson,
and
D.M.Kranz
(2000).
Role of 2CT cell receptor residues in the binding of self- and allo-major histocompatibility complexes.
|
| |
J Exp Med,
191,
1355-1364.
|
 |
|
|
|
|
 |
S.Kumar,
B.Ma,
C.J.Tsai,
N.Sinha,
and
R.Nussinov
(2000).
Folding and binding cascades: dynamic landscapes and population shifts.
|
| |
Protein Sci,
9,
10-19.
|
 |
|
|
|
|
 |
V.Manivel,
N.C.Sahoo,
D.M.Salunke,
and
K.V.Rao
(2000).
Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site.
|
| |
Immunity,
13,
611-620.
|
 |
|
|
|
|
 |
W.B.Watt,
and
A.M.Dean
(2000).
Molecular-functional studies of adaptive genetic variation in prokaryotes and eukaryotes.
|
| |
Annu Rev Genet,
34,
593-622.
|
 |
|
|
|
|
 |
A.B.Martin,
and
P.G.Schultz
(1999).
Opportunities at the interface of chemistry and biology.
|
| |
Trends Cell Biol,
9,
M24-M28.
|
 |
|
|
|
|
 |
B.E.Willcox,
G.F.Gao,
J.R.Wyer,
J.E.Ladbury,
J.I.Bell,
B.K.Jakobsen,
and
P.A.van der Merwe
(1999).
TCR binding to peptide-MHC stabilizes a flexible recognition interface.
|
| |
Immunity,
10,
357-365.
|
 |
|
|
|
|
 |
B.Spiller,
A.Gershenson,
F.H.Arnold,
and
R.C.Stevens
(1999).
A structural view of evolutionary divergence.
|
| |
Proc Natl Acad Sci U S A,
96,
12305-12310.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.J.Tsai,
S.Kumar,
B.Ma,
and
R.Nussinov
(1999).
Folding funnels, binding funnels, and protein function.
|
| |
Protein Sci,
8,
1181-1190.
|
 |
|
|
|
|
 |
J.J.Boniface,
Z.Reich,
D.S.Lyons,
and
M.M.Davis
(1999).
Thermodynamics of T cell receptor binding to peptide-MHC: evidence for a general mechanism of molecular scanning.
|
| |
Proc Natl Acad Sci U S A,
96,
11446-11451.
|
 |
|
|
|
|
 |
J.J.Caguiat,
A.L.Watson,
and
A.O.Summers
(1999).
Cd(II)-responsive and constitutive mutants implicate a novel domain in MerR.
|
| |
J Bacteriol,
181,
3462-3471.
|
 |
|
|
|
|
 |
K.Furukawa,
A.Akasako-Furukawa,
H.Shirai,
H.Nakamura,
and
T.Azuma
(1999).
Junctional amino acids determine the maturation pathway of an antibody.
|
| |
Immunity,
11,
329-338.
|
 |
|
|
|
|
 |
L.O.Hansson,
R.Bolton-Grob,
M.Widersten,
and
B.Mannervik
(1999).
Structural determinants in domain II of human glutathione transferase M2-2 govern the characteristic activities with aminochrome, 2-cyano-1,3-dimethyl-1-nitrosoguanidine, and 1,2-dichloro-4-nitrobenzene.
|
| |
Protein Sci,
8,
2742-2750.
|
 |
|
|
|
|
 |
L.T.Chong,
Y.Duan,
L.Wang,
I.Massova,
and
P.A.Kollman
(1999).
Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7.
|
| |
Proc Natl Acad Sci U S A,
96,
14330-14335.
|
 |
|
|
|
|
 |
P.J.O'Brien,
and
D.Herschlag
(1999).
Catalytic promiscuity and the evolution of new enzymatic activities.
|
| |
Chem Biol,
6,
R91.
|
 |
|
|
|
|
 |
R.W.Roberts,
and
W.W.Ja
(1999).
In vitro selection of nucleic acids and proteins: What are we learning?
|
| |
Curr Opin Struct Biol,
9,
521-529.
|
 |
|
|
|
|
 |
Z.C.Fan,
L.Shan,
B.Z.Goldsteen,
L.W.Guddat,
A.Thakur,
N.F.Landolfi,
M.S.Co,
M.Vasquez,
C.Queen,
P.A.Ramsland,
and
A.B.Edmundson
(1999).
Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
|
| |
J Mol Recognit,
12,
19-32.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.D.Wiens,
V.A.Roberts,
E.A.Whitcomb,
T.O'Hare,
M.P.Stenzel-Poore,
and
M.B.Rittenberg
(1998).
Harmful somatic mutations: lessons from the dark side.
|
| |
Immunol Rev,
162,
197-209.
|
 |
|
|
|
|
 |
G.F.Weiller,
H.S.Rothenfluh,
P.Zylstra,
L.M.Gay,
H.Averdunk,
E.J.Steele,
and
R.V.Blanden
(1998).
Recombination signature of germline immunoglobulin variable genes.
|
| |
Immunol Cell Biol,
76,
179-185.
|
 |
|
|
|
|
 |
I.Fujii,
S.Fukuyama,
Y.Iwabuchi,
and
R.Tanimura
(1998).
Evolving catalytic antibodies in a phage-displayed combinatorial library.
|
| |
Nat Biotechnol,
16,
463-467.
|
 |
|
|
|
|
 |
J.Ren,
R.M.Esnouf,
A.L.Hopkins,
E.Y.Jones,
I.Kirby,
J.Keeling,
C.K.Ross,
B.A.Larder,
D.I.Stuart,
and
D.K.Stammers
(1998).
3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changes.
|
| |
Proc Natl Acad Sci U S A,
95,
9518-9523.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Yu,
S.Y.Choi,
K.D.Moon,
H.H.Chung,
H.J.Youn,
S.Jeong,
H.Park,
and
P.G.Schultz
(1998).
A glycosidase antibody elicited against a chair-like transition state analog by in vitro immunization.
|
| |
Proc Natl Acad Sci U S A,
95,
2880-2884.
|
 |
|
|
|
|
 |
K.Andersson,
J.Wrammert,
and
T.Leanderson
(1998).
Affinity selection and repertoire shift: paradoxes as a consequence of somatic mutation?
|
| |
Immunol Rev,
162,
173-182.
|
 |
|
|
|
|
 |
M.Diaz,
A.S.Greenberg,
and
M.F.Flajnik
(1998).
Somatic hypermutation of the new antigen receptor gene (NAR) in the nurse shark does not generate the repertoire: possible role in antigen-driven reactions in the absence of germinal centers.
|
| |
Proc Natl Acad Sci U S A,
95,
14343-14348.
|
 |
|
|
|
|
 |
M.Diaz,
and
M.F.Flajnik
(1998).
Evolution of somatic hypermutation and gene conversion in adaptive immunity.
|
| |
Immunol Rev,
162,
13-24.
|
 |
|
|
|
|
 |
P.J.Hudson
(1998).
Recombinant antibody fragments.
|
| |
Curr Opin Biotechnol,
9,
395-402.
|
 |
|
|
|
|
 |
R.D.Wood
(1998).
DNA repair: knockouts still mutating after first round.
|
| |
Curr Biol,
8,
R757-R760.
|
 |
|
|
|
|
 |
R.V.Blanden,
H.S.Rothenfluh,
P.Zylstra,
G.F.Weiller,
and
E.J.Steele
(1998).
The signature of somatic hypermutation appears to be written into the germline IgV segment repertoire.
|
| |
Immunol Rev,
162,
117-132.
|
 |
|
|
|
|
 |
T.Azuma
(1998).
Somatic hypermutation in mouse lambda chains.
|
| |
Immunol Rev,
162,
97.
|
 |
|
|
|
|
 |
T.Dörner,
S.J.Foster,
H.P.Brezinschek,
and
P.E.Lipsky
(1998).
Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements.
|
| |
Immunol Rev,
162,
161-171.
|
 |
|
|
|
|
 |
T.Dörner,
S.J.Foster,
N.L.Farner,
and
P.E.Lipsky
(1998).
Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands.
|
| |
Eur J Immunol,
28,
3384-3396.
|
 |
|
|
|
|
 |
Z.J.Chen,
C.J.Wheeler,
W.Shi,
A.J.Wu,
C.H.Yarboro,
M.Gallagher,
and
A.L.Notkins
(1998).
Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire.
|
| |
Eur J Immunol,
28,
989-994.
|
 |
|
|
|
|
 |
H.Zola
(1997).
The development of antibody responses in the infant.
|
| |
Immunol Cell Biol,
75,
587-590.
|
 |
|
|
|
|
 |
S.J.Rowan,
and
J.K.Sanders
(1997).
Enzyme models: design and selection.
|
| |
Curr Opin Chem Biol,
1,
483-490.
|
 |
|
|
|
|
 |
S.Xie,
J.Green,
J.B.Bixby,
B.Szafranska,
J.C.DeMartini,
S.Hecht,
and
R.M.Roberts
(1997).
The diversity and evolutionary relationships of the pregnancy-associated glycoproteins, an aspartic proteinase subfamily consisting of many trophoblast-expressed genes.
|
| |
Proc Natl Acad Sci U S A,
94,
12809-12816.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |